Resultados de la búsqueda

Vicanolo T, Özcan A, Li JL, Huerta-López C, Ballesteros I, Rubio-Ponce A, Dumitru AC, Nicolás-Ávila JÁ, Molina-Moreno M, Reyes-Gutierrez P, Johnston AD, Martone C, Greto E, Quílez-Alvarez A, Calvo E, Bonzon-Kulichenko E, Álvarez-Velez R, Chooi MY, Kwok I, González-Bermúdez B, Malleret B, Espinosa FM, Zhang M, Wang YL, Sun D, Zhen Chong S, El-Armouche A, Kim KK, Udalova IA, Greco V, Garcia R, Vázquez J, Dopazo A, Plaza GR, Alegre-Cebollada J, Uderhardt S, Ng LG, Hidalgo A. Matrix-producing neutrophils populate and shield the skin. Nature (2025) 641:740-748
Link to the full text in Repisalud
Mastrangelo A, Robles-Vera I, Mañanes D, Galán M, Femenía-Muiña M, Redondo-Urzainqui A, Barrero-Rodríguez R, Papaioannou E, Amores-Iniesta J, Devesa A, Lobo-González M, Carreras A, Beck KR, Ivarsson S, Gummesson A, Georgiopoulos G, Rodrigo-Tapias M, Martínez-Cano S, Fernández-López I, Nuñez V, Ferrarini A, Inohara N, Stamatelopoulos K, Benguría A, Cibrian D, Sánchez-Madrid F, Alonso-Herranz V, Dopazo A, Barbas C, Vázquez J, López JA, González-Martín A, Nuñez G, Stellos K, Bergström G, Bäckhed F, Fuster V, Ibañez B, Sancho D. Imidazole propionate is a driver and therapeutic target in atherosclerosis. Nature (2025) 645:254-261
Link to the full text in Repisalud
Cerezo-Wallis D, Rubio-Ponce A, Richter M, Pitino E, Kwok I, Marteletto G, Guanolema-Coba AC, Shih C, Huang RK, Moraga A, Bravo NB, Doré S, Callejas S, Aragonés DG, Jiménez-Carretero D, Martin D, Ovadia S, Vicanolo T, Crainiciuc G, Sicilia J, Deng T, Martin A, Zhang J, Cuartero MI, Giraldo DM, Garcia-Culebras A, Aroca-Crevillen A, Martín-Salamanca S, Torroja C, Ruiz M, Ruano I, Ng MSF, Hou J, Wang Y, Zhang M, Pu J, Herruzo A, van Oordt DC, Chang S, Downie AE, Chen F, Graham AL, Gause WC, Fiset PO, Spicer JD, Heyn H, Zuriaga MA, Bernal JA, Udalova IA, Moro MA, de Bock K, Dopazo A, Fuster JJ, Sánchez-Cabo F, Nieto JC, Calvo GF, Skokowa J, Soehnlein O, Quail DF, Walsh LA, Ng LG, Hidalgo A, Ballesteros I. Architecture of the neutrophil compartment Nature (2025) Dec 3 [Epub ahead of print]
de la Pompa JL. Tunneling through cardiac jelly. Science (2025) 387:1151-1152
Rueda-Alaña E, Senovilla-Ganzo R, Grillo M, Vázquez E, Marco-Salas S, Gallego-Flores T, Ordeñana-Manso A, Ftara A, Escobar L, Benguría A, Quintas A, Dopazo A, Rábano M, Vivanco MD, Aransay AM, Garrigos D, Toval Á, Ferrán JL, Nilsson M, Encinas-Pérez JM, De Pittà M, García-Moreno F. Evolutionary convergence of sensory circuits in the pallium of amniotes. Science (2025) 387:eadp3411
Link to the full text in Repisalud
Gonzalez-Lopez E, Maurer MS, Garcia-Pavia P. Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine. Eur Heart J (2025) 46:999-1013
Link to the full text in Repisalud
Villa Del Campo C, Rivero-García I, Torres M. ERC-funded grant: cardiac regeneration. Eur Heart J (2025) 46:887-889
Byrne RA, Valgimigli M, Bhatt DL, Coughlan JJ, Gibson CM, Rossello X, Gorog DA, Ibanez B, James S, Landi A, Steg PG, Stone GW, Andreotti F. Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months. Eur Heart J (2025) 46:1965-1978
d'Entremont MA, Poorthuis MHF, Fiolet ATL, Amarenco P, Boczar KE, Buysschaert I, Chan NC, Cornel JH, Jannink J, Jansen S, Kedev S, Keech AC, Layland J, Mewton N, Montalescot G, Pascual-Figal DA, Rodriguez AE, Shah B, Teraa M, van Zelm A, Wang Y, Mosterd A, Kelly P, Eikelboom J, Jolly SS. Colchicine for secondary prevention of vascular events: a meta-analysis of trials. Eur Heart J (2025) 46:2564-2575
Pocock SJ, Mendieta G. Colchicine in secondary prevention: making sense out of diversity. Eur Heart J (2025) 46:2576-2578.

Páginas